Cargando…

Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients

AIMS: To evaluate the regression of coronary atherosclerosis with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition in acute coronary syndrome (ACS) patients following primary percutaneous coronary intervention (PPCI). Methods and Result. We examined 40 nontarget lesions in 17 ACS pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yongjun, Yang, Mingming, Chen, Xi, Zhang, Rui, Li, Jing, Zhang, Xiaoguo, Zuo, Pengfei, Ma, Genshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807301/ https://www.ncbi.nlm.nih.gov/pubmed/36632288 http://dx.doi.org/10.1155/2022/4797529

Ejemplares similares

Coronary flow reserve and microcirculatory resistance in patients with coronary tortuosity and without atherosclerosis
por: Li, Yang, et al.
Publicado: (2020)

Spontaneous left main coronary artery dissection occurred in a young male: a case report and review of literature
por: Li, Yongjun, et al.
Publicado: (2022)

Sex Differences in Murray Law‐Based Quantitative Flow Ratio Among Patients With Intermediate Coronary Lesions
por: Zuo, Wenjie, et al.
Publicado: (2023)

Coronary tortuosity is negatively correlated with coronary atherosclerosis
por: Li, Yang, et al.
Publicado: (2018)

Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zuo, Pengfei, et al.
Publicado: (2020)

Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
por: Zhang, Rui, et al.
Publicado: (2022)

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
por: Caselli, Chiara, et al.
Publicado: (2019)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
por: Filatova, Anastasiia Yu., et al.
Publicado: (2023)

Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
por: Gao, Jing, et al.
Publicado: (2021)

The Differences of Quantitative Flow Ratio in Coronary Artery Stenosis with or without Atrial Fibrillation
por: Lu, Wenbin, et al.
Publicado: (2023)

Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
por: Li, Tingting, et al.
Publicado: (2021)

Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
por: Bae, Kwi-Hyun, et al.
Publicado: (2018)

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention
por: Ahn, Jinhee, et al.
Publicado: (2016)

PCSK9 inhibitors for acute coronary syndrome: the era of early implementation
por: Chen, Hongzhen, et al.
Publicado: (2023)

PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
por: Zulkapli, Rahayu, et al.
Publicado: (2023)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

An evaluation of coronary atherosclerosis using coronary CT in subjects with asymptomatic carotid lesions
por: Bonomo, Vito, et al.
Publicado: (2014)

Successful Percutaneous Coronary Intervention for Atherosclerotic Coronary Lesion with Anomalous Origin of the Right Coronary Artery
por: Matsuda, Junji, et al.
Publicado: (2018)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation
por: Shirahama, Ryo, et al.
Publicado: (2018)

Safety and efficacy of the Expressman Extension System for complex coronary lesions during percutaneous coronary intervention
por: Ma, Yanzhuo, et al.
Publicado: (2023)

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke
por: Hopewell, Jemma C, et al.
Publicado: (2018)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Characterization of gut microbiota in adults with coronary atherosclerosis
por: Dong, Yu, et al.
Publicado: (2023)

The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis
por: Chen, Suet Nee, et al.
Publicado: (2009)

Coronary artery fistula and premature coronary atherosclerosis
por: Turek, Łukasz, et al.
Publicado: (2019)

Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial
por: Xia, Jiachun, et al.
Publicado: (2022)

Clinical Implication of Coronary Tortuosity in Patients with Coronary Artery Disease
por: Li, Yang, et al.
Publicado: (2011)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Local fluid dynamics in patients with bifurcated coronary lesions undergoing percutaneous coronary interventions
por: Genuardi, Lorenzo, et al.
Publicado: (2021)

Predictors of Inappropriately Rapid Coronary Lesion Progression in Patients Undergoing Percutaneous Coronary Interventions
por: Sella, Gal, et al.
Publicado: (2023)

Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention
por: Han, Tian-Wen, et al.
Publicado: (2016)

Association of serum PCSK9 levels with platelet function in patients with acute coronary syndromes
por: Wang, Wenting, et al.
Publicado: (2023)

Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy
por: Hirano, Ken-ichi, et al.
Publicado: (2022)

Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention
por: Li, Zhi-Zhong, et al.
Publicado: (2018)

Impact of Hypothyroidism on Outcomes of Percutaneous Coronary Intervention with Coronary Atherectomy for Calcified Coronary Lesions: A Propensity-matched Analysis
por: Desai, Rupak, et al.
Publicado: (2018)

Debate of Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in a Multimorbidity Patient with Complex Coronary Lesions
por: Mitsiadis, Sotirios, et al.
Publicado: (2020)

Association between serum adipsin and plaque vulnerability determined by optical coherence tomography in patients with coronary artery disease
por: Sun, Renhua, et al.
Publicado: (2021)

Impact of Coronary Tortuosity on Coronary Pressure: Numerical Simulation Study
por: Li, Yang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c3mm4l3sphaj9cpgb3vo3e2bnu